Consistently ranked among China’s Top 30 hematopoietic stem cell transplant centres for three consecutive years, reflecting sustained clinical excellence and outcomes.
Formally admitted to the European Society for Blood and Marrow Transplantation (EBMT) in 2025, underscoring international recognition and compliance with global transplantation standards.
Widely acknowledged within the medical community as “Shanghai’s last line of defence for haematology,” highlighting their critical role in managing complex and refractory blood disorders.